Literature DB >> 12525629

Evidence for mixed membrane topology of the newcastle disease virus fusion protein.

Lori W McGinnes1, Julie N Reitter, Kathy Gravel, Trudy G Morrison.   

Abstract

The synthesis of the Newcastle disease virus (NDV) fusion (F) protein in a cell-free protein-synthesizing system containing membranes was characterized. The membrane-associated products were in at least two different topological forms with respect to the membranes. The properties of one form were consistent with the expected membrane insertion as a classical type 1 glycoprotein. This form of the protein was fully glycosylated, and sequences amino terminal to the transmembrane domain were protected from protease digestion by the membranes. The second form of membrane-associated F protein was partially glycosylated and partially protected from protease digestion by the membranes. Protease digestion resulted in a 23-kDa protease-protected polypeptide derived from F2 sequences and sequences from the amino-terminal end of the F1 domain. Furthermore, a 10-kDa polypeptide derived from the cytoplasmic domain (CT) was also protected from protease digestion by the membranes. Protease resistance of the 23- and 10-kDa polypeptides suggested that this second form of F protein inserted in membranes in a polytopic conformation with both the amino-terminal end and the carboxyl-terminal end translocated across membranes. To determine if this second form of the fusion protein could be found in cells expressing the F protein, two different approaches were taken. A polypeptide with the size of the partially translocated F protein was detected by Western analysis of proteins in total-cell extracts of NDV strain B1 (avirulent)-infected Cos-7 cells. Using antibodies raised against a peptide with sequences from the cytoplasmic domain, CT sequences were detected on surfaces of F protein-expressing Cos-7 cells by immunofluorescence and by flow cytometry. This antibody also inhibited the fusion of red blood cells to cells expressing F and HN proteins. These results suggest that NDV F protein made both in a cell-free system and in Cos-7 cells may exist in two topological forms with respect to membranes and that the second form of the protein may be involved in cell-cell fusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525629      PMCID: PMC140911          DOI: 10.1128/jvi.77.3.1951-1963.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion.

Authors:  L Chen; J J Gorman; J McKimm-Breschkin; L J Lawrence; P A Tulloch; B J Smith; P M Colman; M C Lawrence
Journal:  Structure       Date:  2001-03-07       Impact factor: 5.006

Review 2.  Regulation of protein biogenesis at the endoplasmic reticulum membrane.

Authors:  R S Hegde; V R Lingappa
Journal:  Trends Cell Biol       Date:  1999-04       Impact factor: 20.808

Review 3.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

4.  Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.

Authors:  J K Ghosh; S G Peisajovich; Y Shai
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

5.  Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation.

Authors:  C Lambert; R Prange
Journal:  J Biol Chem       Date:  2001-04-11       Impact factor: 5.157

6.  Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion.

Authors:  T Sergel-Germano; C McQuain; T Morrison
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Reorientation of aquaporin-1 topology during maturation in the endoplasmic reticulum.

Authors:  Y Lu; I R Turnbull; A Bragin; K Carveth; A S Verkman; W R Skach
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

8.  Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity.

Authors:  L McGinnes; T Sergel; J Reitter; T Morrison
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

9.  Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.

Authors:  Nicole Pavio; Deborah R Taylor; Michael M C Lai
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.

Authors:  S M Cleveland; T D Jones; N J Dimmock
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

View more
  22 in total

1.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  The adenovirus E3-6.7K protein adopts diverse membrane topologies following posttranslational translocation.

Authors:  Alexander R Moise; Jason R Grant; Roger Lippé; Reinhard Gabathuler; Wilfred A Jefferies
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.

Authors:  Susan R Ross; John W Schmidt; Elad Katz; Laura Cappelli; Stacy Hultine; Phyllis Gimotty; John G Monroe
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.

Authors:  Lori McGinnes Cullen; Madelyn R Schmidt; Trudy G Morrison
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

6.  Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles.

Authors:  Jason P Laliberte; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Characterization of an alternate form of Newcastle disease virus fusion protein.

Authors:  Homer Pantua; Lori W McGinnes; John Leszyk; Trudy G Morrison
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes.

Authors:  L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Lipid-dependent generation of dual topology for a membrane protein.

Authors:  Mikhail Bogdanov; William Dowhan
Journal:  J Biol Chem       Date:  2012-09-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.